These inhibitors primarily target the signaling pathways that regulate angiogenesis. The key pathways involve the Vascular Endothelial Growth Factor (VEGF) and its receptors. By blocking these signals, angiogenesis inhibitors can prevent the growth of new blood vessels, thereby limiting the supply of oxygen and nutrients to tumors or other diseased tissues.
